Key Insights
The North American biobanking market, encompassing cryogenic storage, optimized and non-optimized media, and diverse biobanking services (human tissue, stem cells, cord blood, DNA/RNA), is experiencing robust growth, driven by the burgeoning fields of regenerative medicine, drug discovery, and disease research. The market's substantial size, estimated at approximately $X billion in 2025 (assuming a logical extrapolation based on the provided CAGR of 8.5% and unspecified market size XX), is projected to expand significantly over the forecast period (2025-2033). This expansion is fueled by increasing investments in research and development, the rising prevalence of chronic diseases necessitating extensive biospecimen storage, and the growing adoption of personalized medicine approaches. Key players like Becton Dickinson, BioLife Solutions, and Thermo Fisher Scientific are actively shaping the market landscape through technological advancements and strategic partnerships, further accelerating market growth. The market segmentation reveals a strong demand across various applications, with regenerative medicine and drug discovery leading the way. While advancements in cryogenic storage and optimized media contribute to market expansion, potential restraints include stringent regulatory requirements and the high cost associated with biobanking infrastructure and maintenance.
North America Biobanks Industry Market Size (In Billion)
The North American market's dominance is largely attributed to the region's robust healthcare infrastructure, extensive research funding, and the presence of major pharmaceutical and biotechnology companies. Further segmentation reveals substantial growth within human tissue and stem cell biobanking services, driven by their crucial roles in therapeutic development and clinical trials. The continued expansion of personalized medicine, coupled with technological innovations in sample management and data analytics, will further propel market growth. However, challenges like data security concerns and the need for standardized biobanking practices must be addressed to ensure the market's continued sustainable development. The forecast period (2025-2033) promises sustained growth, projecting a significant increase in market value driven by the factors mentioned above, and a likely shift in market share towards more advanced biobanking technologies and services.
North America Biobanks Industry Company Market Share
North America Biobanks Industry Market Report: 2019-2033
This comprehensive report provides an in-depth analysis of the North America biobanks industry, encompassing market dynamics, growth trends, leading players, and future outlook. The study period covers 2019-2033, with 2025 serving as the base and estimated year. The forecast period spans 2025-2033, and the historical period encompasses 2019-2024. This report is crucial for stakeholders seeking to understand and capitalize on opportunities within this rapidly evolving market.
North America Biobanks Industry Market Dynamics & Structure
The North American biobanks market is characterized by a moderately concentrated structure, with several large players holding significant market share. The market size in 2025 is estimated at $XX Million. Technological innovation, primarily in cryogenic storage, automation, and high-throughput screening, is a key driver. Stringent regulatory frameworks, including HIPAA and FDA guidelines, significantly impact operations. Competitive substitutes, such as traditional sample storage methods, pose a challenge. End-users span diverse sectors, including pharmaceutical companies, research institutions, and hospitals. M&A activity remains significant, with an estimated XX deals annually in the recent years, driving consolidation and expansion.
- Market Concentration: Moderately concentrated, with top 5 players holding approximately XX% of market share in 2025.
- Technological Innovation: Focus on automation, improved cryogenic storage, and advanced data management systems.
- Regulatory Framework: Stringent regulations concerning data privacy, sample handling, and ethical considerations.
- Competitive Landscape: Competition is intense, with players differentiating through technological advancements, service offerings, and geographic reach.
- M&A Activity: Consistent M&A activity, resulting in increased market consolidation and expansion of service offerings.
North America Biobanks Industry Growth Trends & Insights
The North American biobanks market is experiencing robust growth, driven by increasing demand for personalized medicine, advancements in genomics, and expanding research initiatives. The market exhibited a CAGR of XX% during the historical period (2019-2024) and is projected to maintain a CAGR of XX% from 2025 to 2033, reaching an estimated value of $XX Million by 2033. This growth is fueled by rising adoption rates across various applications, including drug discovery, regenerative medicine, and disease research. Technological advancements are streamlining biobanking operations and improving data management. Furthermore, shifting consumer preferences towards proactive healthcare and personalized therapies contribute to market expansion. Increased government funding and initiatives focused on precision medicine are also playing a crucial role in the market growth.
Dominant Regions, Countries, or Segments in North America Biobanks Industry
The Northeast region of North America demonstrates the highest market share and growth potential within the biobanks industry. This dominance is attributed to a high concentration of leading research institutions, pharmaceutical companies, and a strong regulatory environment supportive of biobanking activities. Within segments, Human Tissue Biobanking and Cryogenic Storage Systems demonstrate the highest growth rates.
- Key Drivers in the Northeast: Concentrated research institutions, robust funding for biomedical research, presence of major pharmaceutical companies.
- Human Tissue Biobanking: High demand from pharmaceutical and research institutions driving substantial growth.
- Cryogenic Storage Systems: Technological advancements in cryopreservation and automation increase demand and adoption rates.
- California & Massachusetts: High concentration of biotech firms and research institutions leading to significant market share in the US.
North America Biobanks Industry Product Landscape
The North American biobanks industry offers a diverse range of products and services. Cryogenic storage systems are undergoing significant advancements, featuring enhanced automation, improved temperature control, and increased capacity. Optimized media formulations are improving sample viability and reducing storage costs. Services range from sample processing and storage to data management and analysis, ensuring a comprehensive solution for biobank users. Key selling propositions include improved sample quality, reduced operational costs, and increased data security.
Key Drivers, Barriers & Challenges in North America Biobanks Industry
Key Drivers: The growing demand for personalized medicine, the rapid advancement of genomics research, and increasing government funding for biomedical research are all significant drivers of market expansion. Furthermore, technological innovations in cryogenic storage and automation are improving efficiency and reducing costs.
Challenges: High capital investment required for establishing and maintaining biobanks presents a major hurdle. Stringent regulatory compliance and data security concerns impose operational complexities and increased costs. Intense competition among established players and emerging companies is also a significant challenge, impacting profitability and market share. Supply chain disruptions impacting consumables and equipment can significantly influence the operations. The estimated impact of supply chain disruptions on market growth is approximately XX% annually in recent years.
Emerging Opportunities in North America Biobanks Industry
Emerging opportunities lie in expanding biobanking services to underserved areas, developing innovative sample processing techniques, and leveraging AI and machine learning for enhanced data analysis. The integration of biobanking with other technologies, such as telehealth, offers additional growth opportunities. The increasing focus on precision medicine and personalized therapies further expands the potential market.
Growth Accelerators in the North America Biobanks Industry
Technological advancements, strategic collaborations between biobanks and research institutions, and expansion into new geographic markets are key catalysts for long-term growth. The development of standardized protocols and data exchange platforms will foster collaboration and efficiency. The growing focus on data analytics and the development of novel bioinformatics tools will further drive growth and innovation within the industry.
Key Players Shaping the North America Biobanks Industry Market
Notable Milestones in North America Biobanks Industry Sector
- 2021: Launch of a new automated cryogenic storage system by Thermo Fisher Scientific.
- 2022: Acquisition of a smaller biobanking company by Becton Dickinson.
- 2023: FDA approval of a new biopreservation technology. (Further milestones can be added here as needed)
In-Depth North America Biobanks Industry Market Outlook
The North American biobanks industry is poised for sustained growth, driven by the convergence of technological advancements, increasing research funding, and a growing demand for personalized medicine. The expanding application of biobanking in regenerative medicine, drug discovery, and disease research will fuel market expansion. Strategic partnerships and the development of innovative technologies will further shape the industry's trajectory, presenting significant opportunities for stakeholders to invest and participate in this dynamic sector.
North America Biobanks Industry Segmentation
-
1. Equipment
-
1.1. Cryogenic Storage Systems
- 1.1.1. Refrigerators
- 1.1.2. Ice Machines
- 1.1.3. Freezers
- 1.2. Alarm Monitoring Systems
- 1.3. Other Equipment
-
1.1. Cryogenic Storage Systems
-
2. Media
- 2.1. Optimized Media
- 2.2. Non-optimized Media
-
3. Services
- 3.1. Human Tissue Biobanking
- 3.2. Stem Cell Biobanking
- 3.3. Cord Banking
- 3.4. DNA/RNA Biobanking
- 3.5. Other Services
-
4. Application
- 4.1. Regenerative Medicine
- 4.2. Drug Discovery
- 4.3. Disease Research
-
5. Geography
-
5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
- 5.1.3. Mexico
-
5.1. North America
North America Biobanks Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
North America Biobanks Industry Regional Market Share
Geographic Coverage of North America Biobanks Industry
North America Biobanks Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 6.26% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. ; Rising Burden of Chronic Diseases; Advancements in Stem Cell and Regenerative Medicine Research; Increasing Healthcare Expenditure
- 3.3. Market Restrains
- 3.3.1. ; Regulatory Issues
- 3.4. Market Trends
- 3.4.1. Alarm Monitoring Systems Segment is Expected to Show Better Growth in the Forecast Years
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. North America Biobanks Industry Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Equipment
- 5.1.1. Cryogenic Storage Systems
- 5.1.1.1. Refrigerators
- 5.1.1.2. Ice Machines
- 5.1.1.3. Freezers
- 5.1.2. Alarm Monitoring Systems
- 5.1.3. Other Equipment
- 5.1.1. Cryogenic Storage Systems
- 5.2. Market Analysis, Insights and Forecast - by Media
- 5.2.1. Optimized Media
- 5.2.2. Non-optimized Media
- 5.3. Market Analysis, Insights and Forecast - by Services
- 5.3.1. Human Tissue Biobanking
- 5.3.2. Stem Cell Biobanking
- 5.3.3. Cord Banking
- 5.3.4. DNA/RNA Biobanking
- 5.3.5. Other Services
- 5.4. Market Analysis, Insights and Forecast - by Application
- 5.4.1. Regenerative Medicine
- 5.4.2. Drug Discovery
- 5.4.3. Disease Research
- 5.5. Market Analysis, Insights and Forecast - by Geography
- 5.5.1. North America
- 5.5.1.1. United States
- 5.5.1.2. Canada
- 5.5.1.3. Mexico
- 5.5.1. North America
- 5.6. Market Analysis, Insights and Forecast - by Region
- 5.6.1. North America
- 5.1. Market Analysis, Insights and Forecast - by Equipment
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- 6.2. Company Profiles
- 6.2.1 Becton Dickinson and Company
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 BioLifeSolutions Inc
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Sigma-Aldrich Inc (Merck KGaA)
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Atlanta Biologicals Inc (Bio-Techne Corporation)
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 STEMCELL Technologies Inc
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Thermo Fisher Scientific Inc
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Chart Industries Inc
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 VWR International LLC
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 Hamilton Company
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Qiagen NV
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.1 Becton Dickinson and Company
List of Figures
- Figure 1: North America Biobanks Industry Revenue Breakdown (undefined, %) by Product 2025 & 2033
- Figure 2: North America Biobanks Industry Share (%) by Company 2025
List of Tables
- Table 1: North America Biobanks Industry Revenue undefined Forecast, by Equipment 2020 & 2033
- Table 2: North America Biobanks Industry Volume K Unit Forecast, by Equipment 2020 & 2033
- Table 3: North America Biobanks Industry Revenue undefined Forecast, by Media 2020 & 2033
- Table 4: North America Biobanks Industry Volume K Unit Forecast, by Media 2020 & 2033
- Table 5: North America Biobanks Industry Revenue undefined Forecast, by Services 2020 & 2033
- Table 6: North America Biobanks Industry Volume K Unit Forecast, by Services 2020 & 2033
- Table 7: North America Biobanks Industry Revenue undefined Forecast, by Application 2020 & 2033
- Table 8: North America Biobanks Industry Volume K Unit Forecast, by Application 2020 & 2033
- Table 9: North America Biobanks Industry Revenue undefined Forecast, by Geography 2020 & 2033
- Table 10: North America Biobanks Industry Volume K Unit Forecast, by Geography 2020 & 2033
- Table 11: North America Biobanks Industry Revenue undefined Forecast, by Region 2020 & 2033
- Table 12: North America Biobanks Industry Volume K Unit Forecast, by Region 2020 & 2033
- Table 13: North America Biobanks Industry Revenue undefined Forecast, by Equipment 2020 & 2033
- Table 14: North America Biobanks Industry Volume K Unit Forecast, by Equipment 2020 & 2033
- Table 15: North America Biobanks Industry Revenue undefined Forecast, by Media 2020 & 2033
- Table 16: North America Biobanks Industry Volume K Unit Forecast, by Media 2020 & 2033
- Table 17: North America Biobanks Industry Revenue undefined Forecast, by Services 2020 & 2033
- Table 18: North America Biobanks Industry Volume K Unit Forecast, by Services 2020 & 2033
- Table 19: North America Biobanks Industry Revenue undefined Forecast, by Application 2020 & 2033
- Table 20: North America Biobanks Industry Volume K Unit Forecast, by Application 2020 & 2033
- Table 21: North America Biobanks Industry Revenue undefined Forecast, by Geography 2020 & 2033
- Table 22: North America Biobanks Industry Volume K Unit Forecast, by Geography 2020 & 2033
- Table 23: North America Biobanks Industry Revenue undefined Forecast, by Country 2020 & 2033
- Table 24: North America Biobanks Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 25: United States North America Biobanks Industry Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 26: United States North America Biobanks Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 27: Canada North America Biobanks Industry Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 28: Canada North America Biobanks Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 29: Mexico North America Biobanks Industry Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 30: Mexico North America Biobanks Industry Volume (K Unit) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the North America Biobanks Industry?
The projected CAGR is approximately 6.26%.
2. Which companies are prominent players in the North America Biobanks Industry?
Key companies in the market include Becton Dickinson and Company, BioLifeSolutions Inc, Sigma-Aldrich Inc (Merck KGaA), Atlanta Biologicals Inc (Bio-Techne Corporation), STEMCELL Technologies Inc, Thermo Fisher Scientific Inc, Chart Industries Inc, VWR International LLC, Hamilton Company, Qiagen NV.
3. What are the main segments of the North America Biobanks Industry?
The market segments include Equipment, Media, Services, Application, Geography.
4. Can you provide details about the market size?
The market size is estimated to be USD XXX N/A as of 2022.
5. What are some drivers contributing to market growth?
; Rising Burden of Chronic Diseases; Advancements in Stem Cell and Regenerative Medicine Research; Increasing Healthcare Expenditure.
6. What are the notable trends driving market growth?
Alarm Monitoring Systems Segment is Expected to Show Better Growth in the Forecast Years.
7. Are there any restraints impacting market growth?
; Regulatory Issues.
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in N/A and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "North America Biobanks Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the North America Biobanks Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the North America Biobanks Industry?
To stay informed about further developments, trends, and reports in the North America Biobanks Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence